Cannabinoid Therapies in Less-Common Disorders: Clinical Evidence and Formulation Strategies.

Silvia Afonso, Joana Gonçalves, Ana T Brinca, Luana M Rosendo, Tiago Rosado, Ana Paula Duarte, Eugenia Gallardo

Abstract readReview

In one paragraph

Review in Diseases (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Selected Cannabinoids, Cannabimimetic Agents andPharmaceuticals (Basel, Switzerland) · 2026
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Silvia AfonsoFaculty of Health Sciences, Department of Medical Sciences, University of Beira Interior, Avenida Infante D. Henrique, 6200-506 Covilhã, Portugal.

Joana GonçalvesCentre for the Research and Technology of Agroenvironmental and Biological Sciences, CITAB, Inov4Agro, University of Trás-os-Montes and Alto Douro, UTAD, Quinta de Prados, 5000-801 Vila Real, Portugal.ORCID 0000-0001-8702-415X

Ana T BrincaFaculty of Health Sciences, Department of Medical Sciences, University of Beira Interior, Avenida Infante D. Henrique, 6200-506 Covilhã, Portugal.ORCID 0000-0002-7172-348X

Luana M RosendoFaculty of Health Sciences, Department of Medical Sciences, University of Beira Interior, Avenida Infante D. Henrique, 6200-506 Covilhã, Portugal.ORCID 0000-0002-0461-8540

Tiago RosadoFaculty of Health Sciences, Department of Medical Sciences, University of Beira Interior, Avenida Infante D. Henrique, 6200-506 Covilhã, Portugal.ORCID 0000-0003-0469-2895

Ana Paula DuarteFaculty of Health Sciences, Department of Medical Sciences, University of Beira Interior, Avenida Infante D. Henrique, 6200-506 Covilhã, Portugal.ORCID 0000-0003-3333-5977

Eugenia GallardoFaculty of Health Sciences, Department of Medical Sciences, University of Beira Interior, Avenida Infante D. Henrique, 6200-506 Covilhã, Portugal.ORCID 0000-0002-1802-8998

Funding

Fundação para a Ciência e Tecnologia 2023.03289.BDFundação para a Ciência e Tecnologia 2024.00478.BDFundação para a Ciência e Tecnologia https://doi.org/10.54499/LA/P/0126/2020Fundação para a Ciência e Tecnologia https://doi.org/10.54499/UIDB/00709/2020Fundação para a Ciência e Tecnologia https://doi.org/10.54499/UIDP/00709/2020

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cannabinoidsclinical evidencedrug delivery systemsmedical cannabisrare and complex disorderssafety and regulation

Identifiers

PMID41745121

DOI10.3390/diseases14020083

PMCPMC12939546

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.